Countries Europe

Aptamer Group Signs £465,000 Agreement for Development of Cervical Cancer Blood Test

Agreement for up to £465,000 signed for Optimer development Optimer binders will be developed for use in a cervical cance...

 May 22, 2024 | News

Alnylam and Medison Expand Global Partnership to Accelerate Access to Innovative Therapies

  The expanded partnership will allow Alnylam and Medison to help accelerate access for patients in multiple regions under one glo...

 May 01, 2024 | News

Pfizer and Genmab's TIVDAK Wins FDA Full Approval for Cervical Cancer After Outperforming Chemotherapy in Key Trial

TIVDAK is the first antibody-drug conjugate (ADC) to have positive overall survival data for patients with previously treated recurrent or metastat...

 April 30, 2024 | News

Aptamer and Kairos Biotech Team Up on Optimer+ for Transplant Rejection Treatments

Partnership will use the new Optimer+ platform Optimer+ EM molecules to be developed to help prevent transplant rejection   As part of this agr...

 April 19, 2024 | News

Serum Institute of India and Univercells Unite to Make Personalized Cancer Treatments Widely Available

 Serum Institute of India (SII), the world’s largest vaccine manufacturer, has joined forces with Univercells, a Belgian biotech innovator,...

 April 12, 2024 | News

Sartorius and TheWell Bioscience Partner to Enable More Accurate Predictions in Drug Discovery

Solutions address shift from animal-based to more human-relevant organoid models, resulting in more accurate predictions in drug discovery Synergies wit...

 April 10, 2024 | News

Aptamer Group Files Patent for Cutting-Edge Optimer Binders in Collaboration with Unilever

Aptamer Group plc, the developer of novel Optimer® binders to enable innovation in the life sciences industry, today announces that it has filed a...

 April 09, 2024 | News

Bespak Completes Separation from Recipharm,Shifts Focus to Low GWP Inhalers

Bespak  announced the completion of the transaction to separate Recipharm’s former Advanced Delivery Systems Business Unit from the Recipharm Gr...

 April 02, 2024 | News

South Korean Lunit Forges Ahead in Europe with AI-Enhanced Cancer Detection

  Lunit, a trailblazer in AI-driven diagnostics and cancer treatment,  announced significant strides in its European market presence through new...

 March 19, 2024 | News

Cellectricon launches new Neuroinflammation Research Service

Cellectricon, a services provider dedicated to advancing neuroscience drug discovery, has launched the Neuroinflammation Research Service module. Establish...

 March 13, 2024 | News

Aptamer Group and Unilever Strengthen Ties with Optimer® Development for Consumer Goods

  Aptamer Group plc (AIM: APTA), the developer of novel Optimer® binders to enable innovation in the life sciences industry, today...

 March 11, 2024 | News

TransThera Launches Global Phase 3 Trial for Cholangiocarcinoma in EU, Receives Orphan Drug Status for Tinengotinib from EMA

TransThera, a clinical-stage biopharmaceutical company dedicated to innovating differentiated drugs globally, today announced that the randomized, controll...

 March 11, 2024 | News

Polyplus Expands GMP Offer with Protein Production and Adds GMP Capacity in Belgium

“This is a great time at Polyplus, as we continue to grow our footprint and capabilities under the Sartorius umbrella, fulfilling promises made to su...

 March 06, 2024 | News

Enveric Biosciences Divests Cancer-Targeting Cannabinoid IP to Focus on Mental Health Therapeutics

  Enveric Biosciences (NASDAQ: ENVB), a pioneering biotechnology firm at the forefront of developing neuroplastogenic small-molecule therapeutics, an...

 February 26, 2024 | News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in